Monograph Capital
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Monograph Capital is a life sciences venture firm.
Investor Profile
Monograph Capital has backed more than 12 startups, with 3 new investments in the last 12 months alone. The firm has led 5 rounds, about 42% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series A (50%)
- Series B (42%)
- Series C (8%)
Country Focus
- United States (50%)
- United Kingdom (33%)
- Canada (8%)
- Singapore (8%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Medical
- Therapeutics
- Information Technology
- Biopharma
- Product Research
- Artificial Intelligence (Ai)
- Machine Learning
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
